Use this URL to cite or link to this record in EThOS:
Title: GPR55 : a novel cannabinoid receptor
Author: Ryberg, Erik
Awarding Body: University of Aberdeen
Current Institution: University of Aberdeen
Date of Award: 2009
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
The endocannabinoid system functions through two well characterized receptor systems termed CB1 and CB2.  However a growing body of evidence exists that suggest that the system is more complicated and indicate the presence of additional receptors.  Work by a number of groups in recent years has provided evidence that the system is more complicated and additional receptor types should exist to explain ligand activity in a number of physiological activities. In this thesis it is demonstrated that GPR55 binds to and is activated by the cannabinoid ligand CP55940. In addition endocannabinoids including anandamide and virodhamine activate GPR55 with nM potencies.  Ligands having no CB1 or CB2 activity that are believed to function at some of these novel receptor types such as cannabidiol and abnormal cannabidiol effect activity of GPR55.  These data suggest that GRP55 is a novel cannabinoid receptor, and its relative preference for ligands with respect to CB1 and CB2 described here will permit delineation of its physiological function.  Data also suggesting that GRP55 couples to Gα13 and can mediate activation of RhoA, rac1 and cdc42.  It’s also demonstrated that GPR55 is functionally expressed in the mouse brain and using CB1 and GPR55 selective ligands it is possible to functionally distinguish these receptors. It is therefore probable that both these receptors contribute to cannabinoid activity in CNS function.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available
Keywords: Cannabinoids